Caroline Dive

Caroline Dive

Manchester University

H-index: 92

North America-United States

About Caroline Dive

Caroline Dive, With an exceptional h-index of 92 and a recent h-index of 56 (since 2020), a distinguished researcher at Manchester University, specializes in the field of cancer, SCLC, biomarkers.

His recent articles reflect a diverse array of research interests and contributions to the field:

PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials

86O Serial monitoring of circulating tumor DNA (ctDNA) as a tumor-agnostic biomarker to inform clinical outcomes of patients receiving experimental cancer medicine

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Circulating tumor cells shed large extracellular vesicles in capillary-sized bifurcations

Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions

Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer

Peripheral blood liquid biopsy for the screening of lung cancer

RAS-Bio a unique pan-cancer biobank for RAS-driven tumors

Caroline Dive Information

University

Position

Professor of Pharmacology

Citations(all)

40346

Citations(since 2020)

18304

Cited By

28771

hIndex(all)

92

hIndex(since 2020)

56

i10Index(all)

273

i10Index(since 2020)

169

Email

University Profile Page

Manchester University

Google Scholar

View Google Scholar Profile

Caroline Dive Skills & Research Interests

cancer

SCLC

biomarkers

Top articles of Caroline Dive

Title

Journal

Author(s)

Publication Date

PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials

Luca Agnelli

Andrea Villa

Fouziah Butt

Matteo Duca

Alessandro Guidi

...

2024/4/27

86O Serial monitoring of circulating tumor DNA (ctDNA) as a tumor-agnostic biomarker to inform clinical outcomes of patients receiving experimental cancer medicine

ESMO Open

KS Shohdy

A Ortega Franco

A Saud

R Abdeltawab

M Howell

...

2024/2/1

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Nature Communications

Alicia-Marie Conway

Simon P Pearce

Alexandra Clipson

Steven M Hill

Francesca Chemi

...

2024/4/17

Circulating tumor cells shed large extracellular vesicles in capillary-sized bifurcations

bioRxiv

Angelos Vrynas

Sara Arfan

Karishma Satia

Salime Bazban-Shotorbani

Mymuna Ashna

...

2024

Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions

Science Advances

Joseph B Hiatt

Anna-Lisa Doebley

Henry U Arnold

Mohamed Adil

Holly Sandborg

...

2024/4/10

Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer

bioRxiv

Alessia Catozzi

Maria Peiris-Pages

Sam Humphrey

Mitchell Revill

Derrick Morgan

...

2024

Peripheral blood liquid biopsy for the screening of lung cancer

Cancer Research

Jiyoun Seo

Stephanie N Shishido

Jeremy Mason

Carmen Ruiz Velasco

Andrew Chen

...

2024/3/22

RAS-Bio a unique pan-cancer biobank for RAS-driven tumors

Cancer Research

Mathew Carter

Katherine D Brown

Helen Adderley

George Morrissey

Laura Woodhouse

...

2024/3/22

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: The phase 1 TRIBE trial

Immuno-Oncology and Technology

Kyrillus S Shohdy

Manon Pillai

Kirellos S Abbas

Jennifer Allison

Tom Waddell

...

2024/3/18

Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE

Elife

Matthew Roberts

Julia Ogden

AS Mukarram Hossain

Anshuman Chaturvedi

Alastair RW Kerr

...

2023/3/9

P56 Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection

British Journal of Dermatology

Andy Muinonen-Martin

Rebecca Lee

Dominic Rothwell

Richard Jackson

Nigel Smith

...

2023/6

Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis

Nature Cell Biology

Fangfei Qu

Siqi C Brough

Wojciech Michno

Chioma J Madubata

Griffin G Hartmann

...

2023/10

A novel human model to deconvolve cell-intrinsic phenotypes of genetically dysregulated pathways in lung squamous cell carcinoma

bioRxiv

Julia Ogden

Robert Sellers

Sudhakar Sahoo

Anthony Oojageer

Anshuman Chaturvedi

...

2023

The evolution of lung cancer and impact of subclonal selection in TRACERx

Nature

Charles Swanton

Nicholas McGranahan

Mariam Jamal-Hanjani

Alexander M Frankell

Michelle Dietzen

...

2023/4/20

Lineage plasticity in SCLC generates non-neuroendocrine cells primed for vasculogenic mimicry

Journal of Thoracic Oncology

Sarah M Pearsall

Stuart C Williamson

Sam Humphrey

Ellyn Hughes

Derrick Morgan

...

2023/10/1

Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection

A Muinonen-Martin

Rebecca J Lee

Dominic G Rothwell

R Jackson

Nigel Smith

...

2023

The evolution of non-small cell lung cancer metastases in TRACERx

Nature

Maise Al Bakir

Ariana Huebner

Carlos Martínez-Ruiz

Kristiana Grigoriadis

Thomas BK Watkins

...

2023/4/20

FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy

Cell Reports

Ian G Cannell

Kirsty Sawicka

Isabella Pearsall

Sophia A Wild

Lauren Deighton

...

2023/8/29

A COX-2-based pro-tumourigenic inflammatory signature predicts poor outcome in early-stage non-small cell lung cancer

Cancer Research

Victoria Fife

Matthew Roberts

Christian P Bromley

Derrick Morgan

Sophie Atkinson

...

2023/4/4

Plasticity of circulating tumor cells in small cell lung cancer

Scientific Reports

Jiyoun Seo

Mihir Kumar

Jeremy Mason

Fiona Blackhall

Nicholas Matsumoto

...

2023/7/21

See List of Professors in Caroline Dive University(Manchester University)